These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 11721702

  • 1. Prolactin in human systemic lupus erythematosus.
    Jara LJ, Vera-Lastra O, Miranda JM, Alcala M, Alvarez-Nemegyei J.
    Lupus; 2001; 10(10):748-56. PubMed ID: 11721702
    [Abstract] [Full Text] [Related]

  • 2. Prolactin has a pathogenic role in systemic lupus erythematosus.
    Jara LJ, Medina G, Saavedra MA, Vera-Lastra O, Torres-Aguilar H, Navarro C, Vazquez Del Mercado M, Espinoza LR.
    Immunol Res; 2017 Apr; 65(2):512-523. PubMed ID: 28130617
    [Abstract] [Full Text] [Related]

  • 3. Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus.
    Blanco-Favela F, Chavez-Rueda K, Leaños-Miranda A.
    Lupus; 2001 Apr; 10(10):757-61. PubMed ID: 11721703
    [Abstract] [Full Text] [Related]

  • 4. Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients.
    Blanco-Favela F, Quintal MaG, Chavez-Rueda AK, Leaños-Miranda A, Berron-Peres R, Baca-Ruiz V, Lavalle-Montalvo C.
    Lupus; 2001 Apr; 10(11):803-8. PubMed ID: 11789490
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin.
    Méndez I, Alcocer-Varela J, Parra A, Lava-Zavala A, de la Cruz DA, Alarcón-Segovia D, Larrea F.
    Lupus; 2004 Apr; 13(1):45-53. PubMed ID: 14870917
    [Abstract] [Full Text] [Related]

  • 6. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A, Chávez-Rueda KA, Blanco-Favela F.
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [Abstract] [Full Text] [Related]

  • 7. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia.
    Leaños A, Pascoe D, Fraga A, Blanco-Favela F.
    Lupus; 1998 Apr; 7(6):398-403. PubMed ID: 9736323
    [Abstract] [Full Text] [Related]

  • 8. Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia.
    Paraiba DB, Soares CR, Bartolini P, Arthuso FS, Borba EF, Bonfa E, Bronstein MD.
    Clin Exp Rheumatol; 2010 Apr; 28(6):866-72. PubMed ID: 21205462
    [Abstract] [Full Text] [Related]

  • 9. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases.
    Neidhart M.
    J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986
    [Abstract] [Full Text] [Related]

  • 10. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
    Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda KA, Blanco-Favela F.
    J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460
    [Abstract] [Full Text] [Related]

  • 11. Prolactin and autoimmunity.
    Vera-Lastra O, Jara LJ, Espinoza LR.
    Autoimmun Rev; 2002 Dec; 1(6):360-4. PubMed ID: 12848992
    [Abstract] [Full Text] [Related]

  • 12. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus.
    Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza LR.
    Clin Rheumatol; 1998 Dec; 17(2):110-4. PubMed ID: 9641506
    [Abstract] [Full Text] [Related]

  • 13. Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome.
    Leaños-Miranda A, Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Parra A, Ramírez-Peredo J.
    Lupus; 2007 Dec; 16(5):342-9. PubMed ID: 17576736
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prolactin and autoimmunity.
    De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A.
    Pituitary; 2005 Dec; 8(1):25-30. PubMed ID: 16411065
    [Abstract] [Full Text] [Related]

  • 16. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment.
    Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, Espinoza LR.
    J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507
    [Abstract] [Full Text] [Related]

  • 17. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
    Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Goffin V, Leaños-Miranda A.
    J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
    [Abstract] [Full Text] [Related]

  • 18. Prolactin, dendritic cells, and systemic lupus erythematosus.
    Jara LJ, Benitez G, Medina G.
    Autoimmun Rev; 2008 Jan; 7(3):251-5. PubMed ID: 18190887
    [Abstract] [Full Text] [Related]

  • 19. Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with systemic lupus erythematosus.
    Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda KA, Blanco-Favela F.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2619-24. PubMed ID: 11397862
    [Abstract] [Full Text] [Related]

  • 20. [A review of the effects of prolactin hormone and cytokine on the development and pathogenesis of autoimmune diseases].
    Fojtíková M, Cerná M, Pavelka K.
    Vnitr Lek; 2010 May; 56(5):402-13. PubMed ID: 20578590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.